days). Among dead or discharged patients (n = 2252 [77.5%] overall; n = 774 in surge 1 and n = 1478 in surge 2), surge 2 inhospital mortality was significantly lower compared with that for surge 1 (5.1% vs 12.1%; difference, -7.07%; 95% CI, -9.63% to -4.51%). In-hospital mortality among discharged and deceased ICU-treated patients during surge 2 was not significantly lower than that during surge 1 (49/214 [22.9%] vs 81/295 [27.5%]; difference, -4.56%; 95% CI, -12.15% to 3.03%). The mean daily proportion of individuals with positive RT-PCR results during surge 1 was 13%, whereas it was 25% during surge 2.
No takes yet. Share an insight, caveat, or question.
Kakani et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: